Molecular Characterization of Ovarian Metastases from Colorectal Cancer Using Circulating Tumor DNA Analysis

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Ovarian metastases from colorectal cancer (CRC) are rare but linked to poor prognosis and treatment difficulties.
• These metastases may respond differently to therapy, suggesting unique biological traits.
• The molecular profile of these ovarian tumors is not well understood.

Purpose of the Study:

• To characterize the circulating tumor DNA (ctDNA) landscape in ovarian metastatic CRC.
• To utilize plasma-based deep sequencing for genomic profiling.
• To identify genomic features specific to this metastatic subset.

Main Methods:

• Plasma samples from patients with CRC and ovarian metastases were analyzed.
• Deep sequencing was employed for cancer personalized profiling.
• Pathogenic mutations and copy-number alterations were identified.

Main Results:

• The majority of patients showed detectable pathogenic genomic alterations.
• Common CRC driver mutations (TP53, KRAS, APC) were found at expected frequencies.
• Recurrent amplifications of growth factor receptor genes (EGFR, MET, ERBB2) were identified.

Conclusions:

• CRC ovarian metastases share core genomic features with primary CRC but have distinct receptor tyrosine kinase amplifications.
• These amplifications may indicate adaptation to the ovarian microenvironment.
• Plasma ctDNA profiling offers a viable method for studying this rare metastatic condition and its tumor biology.